This Solicitation opportunity from Department Of Defense was posted on June 23, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

DoW Neurofibromatosis Research Academy – Leadership Award

Closed

HT942526NFRPNFRALAGrant

Submission Closed09/14/2026, 04:00:00 AM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541715

New

Federal

U.S. Army Contracting Command – Watervliet Arsenal (ACC-WVA) Organic Industrial Base (OIB) Modernization Commercial Solutions Opening (CSO)

Solicitation # W911PT26SC001

The U.S. Army Contracting Command – Watervliet Arsenal (ACC-WVA) has issued solicitation W911PT26SC001, a Commercial Solutions Opening (CSO) open continuously until September 30, 2027. This competitive solicitation seeks innovative commercial products, technologies, and services to modernize the Organic Industrial Base (OIB) for Watervliet Arsenal and Benet Laboratories. The primary objective is to integrate manufacturing resources across the enterprise, focusing on linking legacy analogue systems with digital systems, expanding modeling and simulation, and improving the delivery of materiel to soldiers. The CSO is structured around specific Areas of Interest (AoIs) that address diverse needs, including advanced cannon technology, electronic access control systems, electrical infrastructure improvements, automated manufacturing for cannon components, and facility conversions. The acquisition process follows a multi-phased approach consisting of a written solution brief, an optional presentation or pitch, and a final request for a Commercial Solution Proposal (CSP). Evaluation is based on responsiveness, technical merit, uniqueness, and price reasonableness. Successful responses may result in fixed-price contracts awarded under FAR Part 12 Commercial Item Procedures. Eligible participants include traditional and non-traditional business entities, including small businesses and foreign-owned businesses, provided they maintain an active SAM registration and a Unique Entity ID. All submissions must remain unclassified and are evaluated individually against the specific requirements of the applicable Area of Interest.

POSTED

DEADLINE

Silviculture Growth & Yield Modelling Specialist

POSTED

DEADLINE

Mental Health Screening Tool Array Design

COMRESSERVAUTH586 - Community Residential Services Authority

POSTED

DEADLINE

Thermal Performance & Dielectric Testing Laboratory

FA8611 Aflcmc Wauk F22

POSTED

DEADLINE

Clinical Trial Management (Phase I/II)

POSTED

DEADLINE

Biopharmaceutical Platform Design & Development

POSTED

DEADLINE

HERMES BAA CALL: Rotating Detonation Rocket Engine-Combined Cycle (RDRE-CC) Flight Demonstration

Solicitation # FA9300-20-S-0001-CALL-RDRE-CC

The Air Force Research Laboratory Rocket Propulsion Division is seeking innovative research and development to advance Rotating Detonation Rocket Engine-Combined Cycle propulsion systems from Technology Readiness Level 3 to TRL 6. This effort aims to culminate in a ground-launched, sounding-rocket-boosted flight demonstration to support future High-Speed Affordable Mass Munitions. The anticipated period of performance for awarded contracts is between 36 and 48 months. This is a two-step solicitation process under the HERMES Broad Agency Announcement. Step one requires the submission of a white paper by November 16, 2026, which must be limited to ten pages with an optional five-page technical appendix. Only offerors with high technical merit will be invited to step two to submit full technical and cost proposals. Due to the sensitive nature of the technology, detailed requirements are restricted to U.S. Government agencies and vetted contractors with an active Joint Certification Program registration and a valid CAGE code.

POSTED

DEADLINE

Solicitation # SN-27-0002

The Space Development Agency intends to issue a sole source, firm-fixed-price contract modification to SpaceX to maintain a satellite processing and integration facility in Santa Barbara, California. This facility is designed to accommodate up to 21 satellites and their associated dispenser hardware, providing essential services including post-transport functional testing, mechanical and electrical mating, and integrated payload stack encapsulation. The modification is expected to be awarded in December 2026 with an estimated value of 15,000,000 dollars, extending the period of performance for one year. This action is being taken under the authority of FAR 6.302-1, as SpaceX is identified as the only responsible source capable of satisfying the agency's requirements. This notice is for informational purposes and is not a request for competitive proposals.

FA2401 Space Development Agency Sda

POSTED

DEADLINE

L-PBF Development of ODS Alloys for Recording Methane/Oxygen Combustion Properties

Solicitation # 80NSSC27946801Q

The NASA Shared Services Center is seeking capability statements for a project focused on the laser powder bed fusion (L-PBF) development of oxide dispersion strengthened (ODS) and burn-resistant nickel-based alloys, including GRX-810, GRX-810+, and GRX-900. The scope of work involves advanced process development and parameter optimization using an EOS M280 system to achieve a relative density of 99.9 percent or higher. Key requirements include the production of test coupons and representative components, the supply of at least 600 kg of GRX-810 powder, and strict adherence to NASA-STD-6030 for mechanical validation. All deliverables must be shipped to the Marshall Space Flight Center in Huntsville, Alabama. This procurement is being conducted as a commercial items or services acquisition under FAR Part 12, with NAICS code 541715. NASA intends to issue a sole source contract to North American Manufacturing Pros LLC under FAR 12.102(a); however, the agency is requesting capability statements from other interested organizations to determine if the procurement should be conducted on a competitive basis. Interested parties must submit their qualifications to the primary point of contact, Cara Craft, by October 22, 2026. The contract requires rigorous documentation, including real-time reporting of anomalies and full powder traceability certifications covering chemical composition and particle morphology.

NASA Shared Services Center

POSTED

DEADLINE

Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination

Solicitation # HT9427-26-R-E020

The Defense Health Agency Contracting Activity is seeking proposals for the development of a Battlefield Wound Infection Prevention and Treatment Barrier Combination prototype. This product must integrate a physical wound barrier with antimicrobial and antifungal properties to prevent systemic infections in combat scenarios. The project aims to advance the technology to a Technology Readiness Level of 7 or 8, requiring the development of a working prototype, the execution of human clinical trials, and the successful submission for FDA approval or clearance. The final product must be individual, compact, waterproof, and maintain sterilization, with a preference for packaging that allows one-handed opening in low-light environments. This effort is being conducted under the prototype Other Transaction Authority 10 U.S.C. 4022, meaning it does not follow standard FAR-based procurement. To be eligible, offerors must be nontraditional defense contractors, small businesses, or provide significant cost-sharing. The estimated period of performance is 48 months, divided into three objectives: prototype demonstration, clinical studies and regulatory submissions, and final FDA clearance. Proposals will be evaluated based on technical capability, management capability, and cost, with payments processed electronically via Wide Area Workflow. All clinical research must comply with Good Laboratory, Manufacturing, and Clinical Practices, and be approved by relevant Institutional Review Boards and the USAMRDC Office of Human and Animal Research Oversight.

Defense Health Agency

POSTED

DEADLINE

Request for Information – Prophylactic Platform for Medical Countermeasures

Solicitation # W911SR27SPPFC

The Department of Defense, through the Portfolio Management Executive for Chemical, Biological, Radiological and Nuclear Defense (PME CBRND) and the Accelerated Defense Pharmaceuticals (ADP) program, is issuing a Request for Information (RFI) under solicitation W911SR27SPPFC. The objective is to identify capable companies that can advance the development of prophylactic medical countermeasures (MCMs) using existing platform technologies. The program focuses on progressing these countermeasures through Phase I or Phase II clinical trials, with a goal of enabling interim fielding via Expanded Access Protocols or pre-Emergency Use Authorization. The anticipated period of performance is up to four years, with work primarily conducted at the contractor's facilities. Interested respondents must provide a comprehensive capability description, including technical approach, regulatory status with the FDA, cGMP manufacturing capabilities, and a development roadmap with rough order of magnitude cost estimates. Evaluation criteria for future selections will emphasize manufacturing process capability, product safety and efficacy, past FDA experience, and the plug-and-play nature of the platform across various pathogens. Submissions must be delivered as a single searchable PDF, featuring a specific cover page and a core capability description not exceeding four pages. All non-clinical and clinical data must be SEND and CDISC compliant, and manufacturing must adhere to cGMP standards to support an Investigational New Drug application through a Biologics License Application.

POSTED

DEADLINE

ARMY OPEN SOLICITATION (AOS)

Solicitation # W9128Z-25-S-A002

The Army Open Solicitation (AOS), solicitation number W9128Z-25-S-A002, is an indefinite open solicitation issued by the U.S. Army Contracting Command-Aberdeen Proving Ground (ACC-APG) Digital Capability Contracting Center of Excellence. Its primary objective is to support all Army mission areas and maximize Army lethality by rapidly acquiring innovative commercial technologies, research and development solutions, and software acquisition pathway procurements. The AOS leverages a broad range of authorities, including FAR 6.102(d)(2), FAR 35.016 Broad Agency Announcements, and various 10 U.S.C. sections for prototypes and experimental procurements, as well as the Commercial Solutions Opening (CSO) process. Interested parties can engage through two primary methods: responding to Active Capability Gaps (ACG) or submitting proposals in response to specific Calls for Solutions. The award process generally follows a multi-phase approach consisting of a Solution Brief, a Live Pitch, and a final Solution Proposal. Evaluation is based on a hierarchy of Technical Merit, Viability, Feasibility and Desirability, and Schedule and Price. All submissions must be unclassified, and the government does not reimburse companies for costs incurred during the initial three phases of the solicitation process. Key administrative requirements include mandatory registration in the System for Award Management (SAM) and the use of the Wide Area Work Flow (WAWF) for invoicing. Security requirements mandate that all government data reside within the exclusive legal jurisdiction of the United States. Solution Briefs are strictly limited to five written pages in 12-point font or fifteen briefing slides and must be submitted as a single PDF document. While the overall AOS remains open in perpetuity until canceled, individual Calls for Solutions have specific, limited response windows.

W6QK Acc-Apg Contr Ctr

POSTED

1 day ago

DEADLINE

N/A

AI Contract Overview

The fiscal year 2026 Neurofibromatosis Research Program Neurofibromatosis Research Academy Leadership Award, solicitation HT942526NFRPNFRALA, is a grant opportunity from the Defense Health Agency designed to establish a virtual, multi-institutional research academy. The program supports two established investigators—an Academy Director and a Deputy Director—who must both be at or above the level of Associate Professor. The Director, acting as the Initiating PI, and the Deputy Director, acting as the Partnering PI, must be affiliated with different institutions. Together, they will lead a non-traditional training platform for early-career scholars and their mentors, catalyze cross-disciplinary collaboration, and conduct one or more pilot research projects. The award provides a combined total cost cap of 2.4 million dollars over a maximum period of performance of four years. Applications follow a two-step process, requiring a pre-application by August 31, 2026, and a full application by September 14, 2026, submitted via eBRAP or Grants.gov. Selection is based on a two-tier review process evaluating technical merit and programmatic relevance, with specific focus on leadership capabilities, budget appropriateness, and the scientific environment. Applicants must maintain active registrations in SAM.gov, eBRAP, and Grants.gov, and must disclose all foreign affiliations of key personnel to comply with national security requirements.

General Info

DHA grant for two professors to lead a virtual neurofibromatosis research academy.

Agency

Department Of Defense → Defense Health Agency Contracting Activity - Dhaca

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Not specified

Set-Aside

NONE

Documents

HT942526NFRPNFRALA Neurofibromatosis Research Academy Leadership Award

program-announcement

High

HT942526NFRPNFRALA Neurofibromatosis Research Academy Leadership Award Funding Opportunity

funding-opportunity

High

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedJun 23

Solicitation

Response DeadlineSep 14

Deadline has passed

Submission Closed

09/14/2026, 04:00:00 AM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → Defense Health Agency Contracting Activity - Dhaca

Contacts1 person available

OfficeUSA

Organization / AgencyDepartment Of Defense → Defense Health Agency Contracting Activity - Dhaca

Office AddressUSA

Contacts

Ebony S SimmonsGrantor

contact@example.gov

+1 (555) 000-0000

Full Description

Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Neurofibromatosis Research Academy – Leadership Award (NFRALA) supports visionary, established neurofibromatosis (NF) investigators with documented history of neurofibromatosis funding, publications, strong mentorship and commitment to leadership to serve as Director and Deputy Director of the Neurofibromatosis Research Academy. The Academy Director and Deputy Director will execute a multi-institutional, interactive, virtual research academy that consists of scholars, who are early-career investigators, and their career guides, who serve as the scholars’ primary mentors.

Distinctive Features:

• Academy Director: Established NF investigators at or above the level of Associate Professor, or equivalent, at the full application submission deadline.

• Academy Deputy Director: Investigators at or above the level of Associate Professor, or equivalent, at the full application deadline and affiliated with a different institution than the Academy Director.

• Pilot Research Project: The Academy Director and Deputy Director will conduct one or more pilot research projects in collaboration with the academy scholars. Preliminary and/or published data relevant to NF and the proposed research project are encouraged but not required.